The Breast Cancer Research Foundation Announces Launch of the Metastatic Breast Cancer Alliance
The Breast Cancer Research Foundation® (BCRF) is pleased to announce the launch of the Metastatic Breast Cancer Alliance (MBC Alliance). The MBC Alliance, formed by 15 cancer charities and advocacy organizations including BCRF, aims to improve the lives and out comes for those living with metastatic breast cancer and their families, increase awareness and education.
Together, members of the MBC Alliance are working towards a time when:
- All MBC patients and their caregivers can access the care and services they need from a responsive and well-informed healthcare system.
- MBC stakeholders – including those diagnosed and their families, health care providers, researchers, health policy influencers and policy makers — understand MBC and how it differs from early stage breast cancer.
- MBC research focuses on extending life, enhancing quality of life and ultimately ending death from the disease.
Additionally, the MBC Alliance is committed to advancing the global research agenda to focus on extending life, improving the quality of life and ultimately ending death from the disease.
Clifford Hudis, MD, Chairman of BCRF’s Scientific Advisory Board, noted that, "BCRF's membership in the Alliance is an illustration of its longstanding commitment to research on metastasis — how and why it occurs, and how to thwart it. Concerted research efforts will guide more effective detection, prognostication, management and — ideally — prevention strategies."
BCRF's membership in the MBC Alliance is consistent with BCRF's areas of research, including the Evelyn H. Lauder Founder's Fund, created in 2013. This unprecedented initiative is a broad program with a narrow focus, enabling more researchers to analyze the abnormalities in metastatic breast cancer.
"Through the Evelyn H. Lauder Founder’s Fund, BCRF has dedicated $27 million to advancing understanding of why some cancers spread more quickly than others, as well as why some cancers responds so well to therapies while others do not. This multi-year, global collaborative program will focus on dissecting the molecular basis of metastasis using the full range of modern scientific tools," said Larry Norton, MD, BCRF Scientific Director. "The elimination of death and suffering from breast cancer will depend on creative science, and BCRF remains dedicated to this mission."
Founding member organizations of the MBC Alliance include: AdvancedBC.org, Avon Foundation for Women, Breastcancer.org, CancerCare, Cancer Support Community, Dr. Susan Love Research Foundation; Living Beyond Breast Cancer, Metastatic Breast Cancer Network, Research Advocacy Network, SHARE, Sisters Network, Susan G. Komen, The Breast Cancer Research Foundation, Triple Negative Breast Cancer Foundation and Young Survival Coalition. The Alliance is being funded in part by Celgene Corporation, Genentech and Pfizer.
Follow the MBC Alliance: